Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 1:31 AM
Ignite Modification Date:
2025-12-25 @ 1:31 AM
NCT ID:
NCT03208894
Brief Summary:
to see the effects of slabutamol and IV furosemide in the treatment of transient tachypnea of newborn
Study:
NCT03208894
Study Brief:
Protocol Section:
NCT03208894